Navigation Links
Steerable Technologix LLC Announces Release of SurgiSteer Laparoscopic Instruments
Date:6/28/2010

JACKSONVILLE, Fla., June 28 /PRNewswire/ -- Steerable Technologix LLC announces the US release of its SurgiSteer™ laparoscopic instruments.  Developed from licensed technology from OrthoDynamix LLC, the SurgiSteer product line will exploit single port laparoscopic surgery with its steerable 5mm instrumentation. The Lap Grasper, Maryland Dissector and Endo Scissors, available in both free and ratchet handle configurations are simplistic in use versus competitive devices.  "Our design mission was to offer the most robust steerable laparoscopic instrument in the market while offering the surgeon a user friendly product with limited transitional barriers," said Bill Dennis, CEO.  "Our devices exhibit many steerable features that heretofore haven't been available to the surgeon such as high force opening jaws for blunt tissue dissection, strong jaw closing force for reliably driving suture needles, and a very intuitive bend and locking mechanism which eliminates excessive hand motion.  The SurgiSteer product portfolio will increase throughout the year to include RF devices," says Dennis.

Steerable instruments are necessary in one port surgery so as to create the proper orientation and/or triangulation for the surgeon while working through the umbilicus.

Steerable Technologix is a private equity funded medical device developer focused on disposable steerable instruments for general surgery, cardiovascular, spine, and ENT applications.

Steerable Technologix is a Gyrx LLC portfolio company.

SOURCE:  Steerable Technologix LLC

CONTACT:   Bill Dennis, CEO, bdennis@gyrx.com


'/>"/>
SOURCE Steerable Technologix LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... startling report released today, National Safety Council research shows ... plan to eliminate prescription opioid overdoses. Prescription Nation ... the worst drug crisis in recorded U.S. history, assigned a "Making ... , New Mexico , Tennessee ... states, three – Michigan , Missouri ...
(Date:6/23/2016)... Pa. , June 23, 2016 Bracket ... will launch its next generation clinical outcomes platform, Bracket eCOA ... Meeting held on June 26 – 30, 2016 in ... the first electronic Clinical Outcome Assessment product of its kind ... Booth #715. Bracket eCOA 6.0 is a flexible ...
(Date:6/23/2016)... June 23, 2016  Guerbet announced today that it ... Supplier Horizon Award . One of 12 ... recognized for its support of Premier members through exceptional ... excellence, and commitment to lower costs. ... recognition of our outstanding customer service from Premier," says ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 ... brings up a new, often overlooked aspect of head lice: the parasite’s ability to live ... not a common occurrence, but a necessary one in the event that lice have simply ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
Breaking Medicine News(10 mins):